Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,446 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
NeoFLOT: Multicenter phase II study of perioperative chemotherapy in resectable adenocarcinoma of the gastroesophageal junction or gastric adenocarcinoma-Very good response predominantly in patients with intestinal type tumors.
Schulz C, Kullmann F, Kunzmann V, Fuchs M, Geissler M, Vehling-Kaiser U, Stauder H, Wein A, Al-Batran SE, Kubin T, Schäfer C, Stintzing S, Giessen C, Modest DP, Ridwelski K, Heinemann V. Schulz C, et al. Among authors: wein a. Int J Cancer. 2015 Aug 1;137(3):678-85. doi: 10.1002/ijc.29403. Epub 2015 Feb 25. Int J Cancer. 2015. PMID: 25530271 Free article. Clinical Trial.
Capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (mGemOx): final results of a multicenter randomized phase II trial in advanced pancreatic cancer.
Boeck S, Hoehler T, Seipelt G, Mahlberg R, Wein A, Hochhaus A, Boeck HP, Schmid B, Kettner E, Stauch M, Lordick F, Ko Y, Geissler M, Schoppmeyer K, Kojouharoff G, Golf A, Neugebauer S, Heinemann V. Boeck S, et al. Among authors: wein a. Ann Oncol. 2008 Feb;19(2):340-7. doi: 10.1093/annonc/mdm467. Epub 2007 Oct 24. Ann Oncol. 2008. PMID: 17962204 Free article. Clinical Trial.
Weekly high-dose 5-fluorouracil as a 24-h infusion and sodium folinic acid (AIO regimen) plus irinotecan in patients with locally advanced nonresectable and metastatic adenocarcinoma or squamous cell carcinoma of the oesophagus: a phase II trial.
Wolff K, Wein A, Reulbach U, Männlein G, Brückl V, Meier C, Ostermeier N, Schwab SA, Horbach T, Hohenberger W, Hahn EG, Boxberger F. Wolff K, et al. Among authors: wein a. Anticancer Drugs. 2009 Mar;20(3):165-73. doi: 10.1097/CAD.0b013e32831f8ec9. Anticancer Drugs. 2009. PMID: 19125117 Clinical Trial.
Palliative first-line therapy with weekly high-dose 5-fluorouracil and sodium folinic acid as a 24-hour infusion (AIO regimen) combined with weekly irinotecan in patients with metastatic adenocarcinoma of the stomach or esophagogastric junction followed by secondary metastatic resection after downsizing.
Koucky K, Wein A, Konturek PC, Albrecht H, Reulbach U, Männlein G, Wolff K, Ostermeier N, Busse D, Golcher H, Schildberg C, Janka R, Hohenberger W, Hahn EG, Siebler J, Neurath MF, Boxberger F. Koucky K, et al. Among authors: wein a. Med Sci Monit. 2011 May;17(5):CR248-58. doi: 10.12659/msm.881764. Med Sci Monit. 2011. PMID: 21525806 Free PMC article.
Neoadjuvant treatment with weekly high-dose 5-fluorouracil as a 24h-infusion, folinic acid and biweekly oxaliplatin in patients with primary resectable liver metastases of colorectal cancer: long-term results of a phase II trial.
Boxberger F, Albrecht H, Konturek PC, Reulbach U, Maennlein G, Meyer T, Hohenberger W, Hahn EG, Wein A. Boxberger F, et al. Among authors: wein a. Med Sci Monit. 2010 Feb;16(2):CR49-55. Med Sci Monit. 2010. PMID: 20110914 Clinical Trial.
BACKGROUND: In 2003 Wein et al. published data after a short median follow up (23 months). ...Two cycles of chemotherapy were administered, with a third being added when the treatment was well tolerated. Thereafter, curative resection of the liver metastases …
BACKGROUND: In 2003 Wein et al. published data after a short median follow up (23 months). ...Two cycles of chemotherapy were …
Weekly high-dose 5-fluorouracil as 24-h infusion and folinic acid (AIO) plus irinotecan as second- and third-line treatment in patients with colorectal cancer pre-treated with AIO plus oxaliplatin.
Stickel F, Jüngert B, Brueckl V, Schirner I, Brueckl WM, Männlein G, Hegewald J, Mühldorfer S, Bittorf B, Hohenberger W, Hahn EG, Wein A. Stickel F, et al. Among authors: wein a. Anticancer Drugs. 2003 Oct;14(9):745-9. doi: 10.1097/00001813-200310000-00010. Anticancer Drugs. 2003. PMID: 14551509
High-risk groups of patients with Stage II colon carcinoma.
Merkel S, Wein A, Günther K, Papadopoulos T, Hohenberger W, Hermanek P. Merkel S, et al. Among authors: wein a. Cancer. 2001 Sep 15;92(6):1435-43. doi: 10.1002/1097-0142(20010915)92:6<1435::aid-cncr1467>3.0.co;2-n. Cancer. 2001. PMID: 11745220
Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin, and etoposide (ELF) in untreated metastatic gastric cancer.
Moehler M, Eimermacher A, Siebler J, Höhler T, Wein A, Menges M, Flieger D, Junginger T, Geer T, Gracien E, Galle PR, Heike M. Moehler M, et al. Among authors: wein a. Br J Cancer. 2005 Jun 20;92(12):2122-8. doi: 10.1038/sj.bjc.6602649. Br J Cancer. 2005. PMID: 15942629 Free PMC article. Clinical Trial.
1,446 results